Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Proposed sale of Ordinary Shares in Plus500

16th Feb 2026 16:40

RNS Number : 2266T
Plus500 Limited
16 February 2026
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER TO SELL OR ACQUIRE SECURITIES IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR IN ANY OTHER JURISDICTION.

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED BY THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019 (AS FURTHER AMENDED, VARIED OR SUBSTITUTED FROM TIME TO TIME AS A MATTER OF UK LAW). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA THE REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

16 February 2026

Plus500 Ltd.

("Plus500" or the "Company")

Proposed sale of 1,500,000 Existing Ordinary Shares in Plus500

David Zruia, CEO of Plus500, Elad Even-Chen, CFO of Plus500 and Nir Zats, CMO of Plus500 (together the "Selling Shareholders"), announce their intention to sell 1,500,000 existing ordinary shares (the "Shares") in the capital of Plus500. The Shares represent approximately 2.14% of the Company's issued share capital (excluding ordinary shares held in treasury).

The Shares will be sold on the secondary market to Goldman Sachs International ("Goldman Sachs") as principal, with the sale intermediated by Panmure Liberum Limited ("Panmure Liberum"). Goldman Sachs may or may not onward sell the Shares. Plus500 is not a party to the transaction and will not receive any proceeds from the transaction.

The transaction is being undertaken by the Selling Shareholders for personal financial and tax planning purposes. The Selling Shareholders have not sold any shares in the Company since its IPO 13 years ago and remain highly committed to the Company's long-term strategy, growth trajectory and value creation for shareholders.

Further details are set out below:

 

Shares to be sold as part of the transaction

Resultant 2026 shareholding assuming all Shares are sold[1]

Selling Shareholder

# of Shares

% of S/O

# of Shares

% of S/O

David Zruia

450,792

0.64%

1,298,468

1.85%

Elad Even-Chen

940,000

1.34%

1,298,468

1.85%

Nir Zats

109,208

0.16%

131,316

0.19%

Total

1,500,000

2.14%

2,728,252

3.89%

Assuming all the Shares are sold, after completion of the transaction, the Selling Shareholders will continue to hold approximately 3.89%1 of the issued share capital of the Company. The Shares, in all respects, rank pari passu with the Company's ordinary shares.

The Selling Shareholders have agreed with Panmure Liberum not to sell any further ordinary shares they hold in the capital of the Company for a period of 365 days after completion of the transaction, subject to waiver by Panmure Liberum ("Lock-in Period").

For further details:

Panmure Liberum

Bidhi Bhoma, Dru Danford, David Watkins, Satbir Kler

 

+44 20 3100 2000

 


[1] The total resultant shareholding assuming all 1,500,000 Shares are sold is 2,728,252. This comprises 1,450,001 ordinary shares held as at the date of this announcement and 1,278,251 ordinary shares expected to vest during 2026 subject to performance conditions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVRFFIRLIR

Related Shares:

Plus500
FTSE 100 Latest
Value10,473.69
Change27.34